Pharmacists' knowledge about use of topical corticosteroids in atopic dermatitis: Pre and post continuing professional development education
Authors:
- 5 April 2015
- journal article
- research article
- Published by Wiley in Australasian Journal of Dermatology
- Vol. 57 (3) , 199-204
Abstract
Background/Objectives: Topical corticosteroids (TCS) are the standard of care in paediatric atopic dermatitis (pAD). Parents commonly cite TCS phobia as a major impediment to treatment adherence. Misinformation on TCS side‐effects can impact on perceptions of TCS safety. We aimed to assess pharmacists' beliefs and information on the safety of TCS in pAD treatment and determine whether their beliefs could be modified.Methods: Australian pharmacists attending a continuing professional development conference were assessed before and after an evidence‐based lecture on the use of TCS in pAD. Responses were recorded in real time on electronic keypads.Results: The mean response rate was 86% of the 292 surveyed. Of responders, 64% recognised that treatment non‐adherence was a major reason for treatment failure in pAD. The post‐education session assessment demonstrated a major attitude shift compared to the pre‐education assessment. After education, pharmacists would instruct parents/patients to apply TCS until the eczema is clear (27 vs 92% pre and post‐education, P < 0.0001). The proportion that would instruct patients to use TCS sparingly dropped from 54 to 8% (P < 0.0001). The belief that cutaneous atrophy was the commonest side‐effect dropped from 46 to 7% (P < 0.0001). The belief that side‐effects from TCS would occur, even if used appropriately, dropped from 56 to 11% post‐education (P < 0.0001).Conclusions: The significant knowledge gaps about the use and safety of TCS in pAD in Australian pharmacists and their advice to patients potentially contributes to poor treatment concordance. These attitudes appear modifiable through targeted, evidence‐based education delivered by a dermatologist.Keywords
Funding Information
- Merck Sharpe
- Dohme
This publication has 22 references indexed in Scilit:
- Experiences of carers managing childhood eczema and their views on its treatment: a qualitative studyBritish Journal of General Practice, 2012
- Evaluation of the Atrophogenic Potential of Topical Corticosteroids in Pediatric Dermatology PatientsPediatric Dermatology, 2011
- Corticosteroid phobia and other confounders in the treatment of childhood atopic dermatitis explored using parent focus groupsAustralasian Journal of Dermatology, 2010
- Expert consensus: time for a change in the way we advise our patients to use topical corticosteroidsBritish Journal of Dermatology, 2008
- Steroid fears in children with eczemaActa Paediatrica, 2006
- Community pharmacists’ role in managing common skin problemsBritish Journal of Dermatology, 2006
- Determining the relative importance of patient motivations for nonadherence to topical corticosteroid therapy in psoriasisJournal of the American Academy of Dermatology, 2006
- The psychosocial burden of childhood atopic dermatitisDermatologic Therapy, 2006
- The Burden of Atopic Dermatitis: Impact on the Patient, Family, and SocietyPediatric Dermatology, 2005
- Quality of life and disease severity are correlated in children with atopic dermatitisBritish Journal of Dermatology, 2004